The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes

NCT00044148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: LY333531

Sponsor

Chromaderm, Inc.